In its response to a federal request for input, NAMD aligns with CMS’s goal to enhance the efficiency and effectiveness of the federal process for developing and acquiring technology and systems to support the Medicaid program. Read full letter.
NAMD provided comments to leaders of the House Energy and Commerce Committee on their draft proposal to establish a pediatric health home option for Medicaid children with medically complex conditions. Read full letter.
Today, Matt Salo, executive director of the National Association of Medicaid Directors, gave testimony before the House Energy and Commerce Committee, Subcommittee on Health, on “Examining the Advancing Care for Exceptional Kids Act.” Read full testimony.
NAMD submitted comments to CMS on the proposed rule implementing the Merit-based Incentive Payment System and Advanced Alternative Payment Model (APM) programs, which were created under the Medicare Access and CHIP Reauthorization Act of 2015. NAMD’s comments discuss the impact of the rule on state Medicaid payment and delivery system reform, and explore unique Medicaid […]
This new issue brief – developed with the support of The Commonwealth Fund – explores the importance of Medicaid state-led work in national conversations on value-based purchasing (VBP). It also explores the potential for state and federal efforts to be aligned in VBP development to achieve the maximum effect in improving health, improving care and […]
NAMD partnered with the National Association of States United for Aging and Disability (NASUAD), the National Association of State Directors of Developmental Disabilities Services (NASDDDS), and the National Association of State Mental Health Program Directors (NASMHPD) to send a joint letter to the Department of Labor (DOL). The letter outlines the state associations’ concerns with […]
NAMD submitted comments to the Health Care Payment Learning Action Network on its draft white paper on clinical episode payment for maternity care. The comments highlight state Medicaid considerations when designing a clinical episode payment model for maternity care. Read full letter.
On May 18, NAMD submitted comments to the Health Resources and Services Administration (HRSA) in response to reopened provisions of a proposed rule on the 340B drug discount program. NAMD called for HRSA to maintain its initially proposed “penny pricing” method for 340B drugs, for HRSA to align the 340B ceiling price for new drugs […]